XNAS
TLSI
Market cap261mUSD
Oct 07, Last price
4.25USD
1D
-0.47%
1Q
9.25%
IPO
-64.58%
Name
Medtech Acquisition Corp
Chart & performance
P/E
—
P/S
5.80
EPS
—
Div yield, %
—
Shrs. gr., 5y
4.40%
Rev. gr., 5y
%
Revenues
45m
+53.41%
Net income
-39m
L+18.04%
CFO
-18m
L-55.90%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MedTech Acquisition Corporation currently has no significant active business operations. The firm's stated intention is to pursue and finalize a business combination — which could involve a merger, stock exchange, asset acquisition, or other forms of corporate restructuring — with one or more enterprises in the U.S. healthcare industry. Established in 2020, its corporate base is situated in Greenwich, Connecticut.
Key people
President, Chief Executive Officer, Director · since 2023
Jodi Devlin
President - Commercial Operations · since 2023
Richard Marshak
Senior Vice President - Corporate Development, Strategy, & Marketing · since 2023
Dan Giordano
Vice President - Finance · since 2025
James Young
Chief Financial Officer, Treasurer, Secretary · since 2025
Bryan Cox
Chief of Research · since 2023
Jennifer Stevens
Chief Regulatory Officer · since 2023
Gary Gordon
Director · since 2025
Sean Murphy
Director · since 2025
William Valle
Director · since 2025
Kerry Hicks
Independent Director · since 2023
Independent Director · since 2023
Andrew von Eschenbach
Independent Director · since 2023
Independent Non-Executive Chairman of the Board · since 2023
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||